NHP IPO Deep Dive: Valuation, Yield, and SHOP vs. OMF

The NHP IPO brings a healthcare REIT to market with two very different earnings engines: higher-beta senior housing in SHOP and steadier outpatient medical cash flow in OMF. 

Additionally, the NHP IPO is not a pure yield trade. It is a balance-sheet reset paired with a bet that senior housing operating leverage can lift earnings faster than the headline numbers suggest.

Key Takeaways

• NHP plans to offer 38.5 million shares priced between $13 and $16, anticipating proceeds of approximately $558.25 million at the midpoint.

• NHP reported $342.3 million in revenue for 2025, but still faced a $71.1 million net loss attributable to common stockholders. As a result, the IPO is being marketed based on expected future performance and operating leverage rather than current GAAP earnings.

• SHOP is the faster-moving segment while OMF remains the balance-sheet ballast.

• OMF generated $79.8 million in 2025 cash NOI, compared to $42.6 million for SHOP. It indicates that approximately 65% of segment cash NOI came from outpatient medical assets, while about 35% came from senior housing.

• Leverage is still meaningful. Year-end net debt stood at $988.6 million, with a gross asset value of $2.2 billion and a total debt leverage of 45.1%.

What Does the NHP IPO Valuation Look Like?

Table source: NHP prospectus, IPO calendar data, and cited calculations.

NHP is entering the public market with a substantial size for REIT investors, although it still carries execution risks that should not be overlooked. 

At the midpoint of the offering, the deal is expected to raise approximately $558 million, and the upper end of the range suggests an equity valuation of around $1.1 billion. This places the stock in a position where swift deleveraging and effective earnings conversion are essential.

The valuation debate turns on whether investors price NHP as a stabilized healthcare landlord or as a transition story. On one hand, Gross borrowings totaled approximately $1.0 billion, with a weighted-average interest rate of 5.94%, keeping funding costs relevant.

On the other hand, using midpoint IPO math and year-end net debt, enterprise value screens below gross asset value, suggesting the stock is not being floated at an aggressive premium to real estate exposure. That discount only matters if management converts better SHOP fundamentals into durable FFO. 

Where Is the Yield in the NHP IPO?

The near-term yield outlook is clearer in NHP's preferred securities than in the IPO common stock. 

The company intends to pay regular quarterly common dividends after listing, but it has not paid cash common dividends since mid-2020. By contrast, the listed preferreds have fixed coupons and currently trade at current yields above 8%. 

That distinction matters. Series A preferred pays $1.84375 annually, or 7.375% on its $25 liquidation preference, while Series B pays $1.78125, or 7.125%. Based on current market prices near $21.65 and $21.25, those translate into current yields of about 8.52% and 8.38%, respectively. 

Management also repurchased preferred shares in 2025 at a weighted-average yield of 11.5%, showing it understood where its own capital stack had been mispriced. 

For common shareholders, yield will depend less on headline REIT optics and more on taxable income, post-IPO leverage, and acquisition pacing. In practical terms, the NHP IPO is better read today as a rerating candidate than as a finished income vehicle.

SHOP vs. OMF: Which Engine Matters More?

OMF is the larger cash-flow base today, but SHOP is the segment that can move the multiple. OMF provides the defensive income stream and occupancy stability that anchors the REIT. SHOP, because it is fully operated under RIDEA structures, gives NHP direct exposure to rent growth, occupancy recovery, and margin expansion.

Table Source: NHP prospectus and cited calculations.

The strategic split is straightforward. OMF is the store-of-value segment: 92.8% occupied, largely tied to health systems, and positioned as the capital-recycling base. 

SHOP is the operating leverage sleeve: same-store occupancy rose to 84.6% in Q4 2025 from 81.1% a year earlier, while same-store cash NOI margin improved to 20.8% from 18.2%. That is the piece public investors will likely reward if the trend holds through 2026.

What Could Derail the NHP IPO Case?

The main risks are leverage, dividend ambiguity on the common, and execution risk inside SHOP. NHP still enters the IPO with meaningful debt and a recent history of common distributions paid in stock rather than cash. If SHOP occupancy gains stall or financing costs stay high, the rerating case weakens quickly.

Two additional points deserve attention. First, NHP's only variable-rate debt at year-end was the $186 million revolver, and a 100-basis-point rate increase would add about $1.9 million in annualized interest expense, so rate sensitivity has not disappeared. 

Second, the senior housing thesis is strong at the industry level, but investors still need proof that demographic tailwinds translate into issuer-level FFO growth. 

The filing itself points to a projected shortage of more than 2.5 million senior housing units by 2035 and notes that people aged 65 and over account for 35% of healthcare spending, yet those sector drivers do not eliminate company-specific execution risk.

FAQ

Is NHP a Pure Senior Housing REIT?

No. NHP is a hybrid healthcare REIT with 37 senior housing communities in SHOP and 130 outpatient medical facilities in OMF.

Does the NHP IPO Offer a Dividend Yield on Common Stock?

Not yet. NHP says it intends to pay regular quarterly common dividends, but it did not pay cash common dividends in 2025. The cleaner current-income instruments remain the listed preferred shares, which now yield above 8% at market prices.

What Is the Biggest Issue Investors Should Watch After Listing?

Watch whether debt reduction and SHOP operating momentum translate into better FFO. The company's revenue scale is established, but it still reported a net loss for 2025. Consequently, post-IPO earnings conversion will determine the stock's credibility.

The Bottom Line

The NHP IPO is a transition trade inside a healthcare REIT wrapper. OMF gives investors defensive cash flow. SHOP provides the story with significant potential for multiple expansions. 

This combination can succeed, but only if the IPO effectively reduces leverage and the momentum in senior housing continues to strengthen, leading to cleaner common-share earnings.

Until then, yield belongs more to the preferreds than to the common, and valuation belongs more to execution than to asset quality alone.